Cargando…
Secondary Abdominal Cocoon Syndrome Due To Chronic Beta-Blocker Use
Sclerosing encapsulating peritonitis (SEP), which is interchangeably used with the term ‘’abdominal cocoon syndrome’’, is a rare condition characterized by a thick fibrous membrane encasing portions of the intestinal wall leading to recurrent bowel obstructions. To date, literature describing the as...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571602/ https://www.ncbi.nlm.nih.gov/pubmed/33094050 http://dx.doi.org/10.7759/cureus.10509 |
_version_ | 1783597200879648768 |
---|---|
author | Asotibe, Jennifer C Zargar, Pejman Achebe, Ikechukwu Mba, Benjamin Kotwal, Vikram |
author_facet | Asotibe, Jennifer C Zargar, Pejman Achebe, Ikechukwu Mba, Benjamin Kotwal, Vikram |
author_sort | Asotibe, Jennifer C |
collection | PubMed |
description | Sclerosing encapsulating peritonitis (SEP), which is interchangeably used with the term ‘’abdominal cocoon syndrome’’, is a rare condition characterized by a thick fibrous membrane encasing portions of the intestinal wall leading to recurrent bowel obstructions. To date, literature describing the association between this condition and chronic beta-blocker therapy is scarce. This report adds by detailing a rare presentation of SEP and highlights an understudied yet important association of SEP with chronic beta-blocker therapy. |
format | Online Article Text |
id | pubmed-7571602 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-75716022020-10-21 Secondary Abdominal Cocoon Syndrome Due To Chronic Beta-Blocker Use Asotibe, Jennifer C Zargar, Pejman Achebe, Ikechukwu Mba, Benjamin Kotwal, Vikram Cureus Gastroenterology Sclerosing encapsulating peritonitis (SEP), which is interchangeably used with the term ‘’abdominal cocoon syndrome’’, is a rare condition characterized by a thick fibrous membrane encasing portions of the intestinal wall leading to recurrent bowel obstructions. To date, literature describing the association between this condition and chronic beta-blocker therapy is scarce. This report adds by detailing a rare presentation of SEP and highlights an understudied yet important association of SEP with chronic beta-blocker therapy. Cureus 2020-09-17 /pmc/articles/PMC7571602/ /pubmed/33094050 http://dx.doi.org/10.7759/cureus.10509 Text en Copyright © 2020, Asotibe et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Gastroenterology Asotibe, Jennifer C Zargar, Pejman Achebe, Ikechukwu Mba, Benjamin Kotwal, Vikram Secondary Abdominal Cocoon Syndrome Due To Chronic Beta-Blocker Use |
title | Secondary Abdominal Cocoon Syndrome Due To Chronic Beta-Blocker Use |
title_full | Secondary Abdominal Cocoon Syndrome Due To Chronic Beta-Blocker Use |
title_fullStr | Secondary Abdominal Cocoon Syndrome Due To Chronic Beta-Blocker Use |
title_full_unstemmed | Secondary Abdominal Cocoon Syndrome Due To Chronic Beta-Blocker Use |
title_short | Secondary Abdominal Cocoon Syndrome Due To Chronic Beta-Blocker Use |
title_sort | secondary abdominal cocoon syndrome due to chronic beta-blocker use |
topic | Gastroenterology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571602/ https://www.ncbi.nlm.nih.gov/pubmed/33094050 http://dx.doi.org/10.7759/cureus.10509 |
work_keys_str_mv | AT asotibejenniferc secondaryabdominalcocoonsyndromeduetochronicbetablockeruse AT zargarpejman secondaryabdominalcocoonsyndromeduetochronicbetablockeruse AT achebeikechukwu secondaryabdominalcocoonsyndromeduetochronicbetablockeruse AT mbabenjamin secondaryabdominalcocoonsyndromeduetochronicbetablockeruse AT kotwalvikram secondaryabdominalcocoonsyndromeduetochronicbetablockeruse |